
Addus HomeCare’s first quarter results were met with a negative market reaction, largely due to revenue falling short of Wall Street’s expectations despite healthy year-on-year growth. Management cited a combination of weather-related disruption in January and flat sales volumes as factors impacting top-line performance. CEO Dirk Allison noted that while some personal care visits could not be rescheduled after severe winter storms, operational trends normalized in February and March. The company also highlighted improvements in its hospice segment and continued benefits from recent acquisitions, with rate increases in key states such as Illinois and Texas supporting margins.
Is now the time to buy ADUS? Find out in our full research report (it’s free for active Edge members).
Addus HomeCare (ADUS) Q1 CY2026 Highlights:
- Revenue: $363.6 million vs analyst estimates of $366.2 million (7.7% year-on-year growth, 0.7% miss)
- Adjusted EPS: $1.62 vs analyst estimates of $1.54 (4.9% beat)
- Adjusted EBITDA: $44.51 million vs analyst estimates of $44.22 million (12.2% margin, 0.7% beat)
- Operating Margin: 9.4%, in line with the same quarter last year
- Sales Volumes were flat year on year (33.8% in the same quarter last year)
- Market Capitalization: $1.82 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Addus HomeCare’s Q1 Earnings Call
- Brian Tanquilut (Jefferies) asked about the impact and benefits of the caregiver app rollout in Texas. President and COO Heather Dixon explained that early adoption rates were encouraging and outlined plans for further deployment to boost service percentage and engagement.
- Raj Kumar (Stephens) inquired about rate trends in Indiana following recent acquisitions. CFO Brian Poff responded that Indiana’s rates have become more attractive, making simultaneous acquisitions particularly appealing for geographic scale.
- Matthew Gillmor (KeyBanc) probed sequential census trends in personal care and the effect of weather disruptions. Dixon confirmed that census improved through March, with Illinois showing particular strength, and described the dip as seasonal rather than structural.
- Michael Murray (RBC Capital) questioned whether SG&A leverage was due to the caregiver app or other cost initiatives. Poff clarified that SG&A improvements stemmed from revenue growth and corporate cost discipline, not directly from the app.
- Albert Rice (UBS) asked about the outlook for personal care and hospice growth rates through the year. Poff reiterated expectations for continued above-average growth and noted that rate updates and state budgets would influence results in the second half.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) the pace of caregiver app adoption and its impact on authorized hour utilization, (2) the integration and initial performance of Indiana acquisitions as a test case for further geographic expansion, and (3) updates on state rate reviews and Medicaid regulatory changes, which could affect both revenue growth and industry dynamics. Progress on these fronts will be key to Addus HomeCare’s execution of its strategic plan.
Addus HomeCare currently trades at $99.57, in line with $100.12 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
The Best Stocks for High-Quality Investors
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.